Every two minutes, a man is diagnosed with prostate cancer in our country. This disease is currently the second-leading cancer-related killer of men in the United States.
A new study published in the Nature Scientific Reports highlighted the potential benefits of aspirin in reducing biochemical recurrence (BCR) rates following robot-assisted radical ...